BLO Cannabix Technologies Inc

501-3292 Production Way, Burnaby, B.C., V5A 4R4
Phone: (604) 551-7831       Fax: 604-676-2767

info@cannabixtechnologies.com
cannabixtechnologies.com
 

Cannabix has developed a contactless alcohol breathalyzer for vehicles. New Standards Coming for New Vehicles in the USA and Europe

Vancouver, British Columbia -- April 20, 2022 -- InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the "Company or Cannabix") developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company has developed a cutting-edge Contactless Alcohol Breathalyzer for vehicle cabins. The prototype Contactless Alcohol Breathalyzer ("CAB") was developed by Cannabix after being approached by a Tier 1 global automobile parts manufacturing company seeking to source new technology that could be used in a contactless (no straw, no mouthpiece) method. The Company has entered into a non-disclosure agreement with the Tier 1 global automobile parts manufacturer. The first proof of concept prototype of the CAB has been developed for a vehicle cabin with specialized placement of such technology. Cannabix has used its years of experience in breath testing and breath capture technology for marijuana to rapidly develop a working CAB prototype, with a small enough footprint that could be developed for virtually any make or model vehicle. The Company has not entered into any contractual relationship for its CAB technology. The Company has filed a provisional patent application for its CAB technology.

The first CAB proof of concept prototype would allow for a driver to direct a breath sample towards a small orifice integrated into the cabin of a vehicle - in a completely contactless manner. The CAB is fundamentally different than existing alcohol interlock systems that require users to use a mouthpiece and directly blow into a handheld device that is connected to the vehicle usually with a cable. The Cannabix CAB has been designed for specific placement inside the vehicle cabin, however could be outfitted various locations in the vehicle cabin. The CAB provides a warning, pass or fail result along with a Blood Alcohol Content (BAC) level on the screen for the driver to see. This kind of technology holds potential to be integrated with interlock systems and be used in many settings including automotive, heavy-duty equipment including heavy transport vehicles, watercraft and workplace monitoring.

In the United States, the November 2021 Infrastructure Investment and Jobs Act (IIJA) passed by the House of Representatives called for new cars to come equipped with technology that will detect alcohol in breath. The legislation directs the National Highway Traffic Safety Administration to set new safety standards within three years for impaired driving safety equipment on all new vehicles (1) (2).

Manufacturers such as Volvo have experimented with offering alcohol-detection systems as optional equipment. A public-private partnership called the Driver Alcohol Detection System for Safety (DADSS) project is also testing their own system.

(1)   https://www.iihs.org/news/detail/alcohol-detection-systems-could-prevent-more-than-a-fourth-of-u-s-road-fatalities

(2)  https://www.madd.org/press-release/auto-technology-that-stops-drunk-driving-now-required-by-law

Readers are cautioned that, although the Company has achieved proof of concept prototype for the CAB, the testing method and device is still in the preapproval stage and accordingly the Company is not currently making any express or implied claims that the technology will proceed to commercial use.

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace. Cannabix is working to develop drug-screening devices that will detect THC - the psychoactive component of marijuana that causes impairment using breath samples. Breath testing for THC would allow employers and law enforcement to identify recent marijuana use that better aligns with impairment. Cannabix devices are in the advanced prototype and pre-clinical testing stage.

We seek Safe Harbor.  

 On behalf of the Board of Directors

"Rav Mlait"

CEO

Cannabix Technologies Inc.

For further information, contact the Company at info@cannabixtechnologies.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Statements
 

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (iv) the ability of the Company to develop and market its future product; and (v) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that its development of breathalyzer technology will provide any benefit to the Company, and no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials. The is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies. There is no assurance that any "patent pending" or "provisional patents" technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities.  The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Grafico Azioni Cannabix Technologies (CSE:BLO)
Storico
Da Dic 2024 a Gen 2025

Grafico Azioni Cannabix Technologies (CSE:BLO)
Storico
Da Gen 2024 a Gen 2025